[Comparison of the Incidence of Febrile Neutropenia in Doxorubicin/Cyclophosphamide(AC)and Docetaxel/Cyclophosphamide(TC) Perioperative Chemotherapies for Primary Breast Cancer].

Nohara, Yuki; Ono, Shuko; Tanaka, Masumi; Yoshinaga, Yasuteru; Ito, Toshikazu; Yamashita, Shinichi; Iwasaki, Akinori

Nohara, Yuki; Ono, Shuko; Tanaka, Masumi; Yoshinaga, Yasuteru; Ito, Toshikazu; Yamashita, Shinichi; Iwasaki, Akinori.

Affiliation

Nohara Y; Dept. of General Thoracic, Breast, Endocrine and Pediatric Surgery, Fukuoka University, Faculty of Medicine.

Gan To Kagaku Ryoho ; 47(11): 1589-1591, 2020 Nov.

Article in Ja | MEDLINE | ID: mdl-33268733

Subject(s)

Breast Neoplasms; Febrile Neutropenia; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Breast Neoplasms/drug therapy; Cyclophosphamide/adverse effects; Docetaxel/adverse effects; Doxorubicin/adverse effects; Febrile Neutropenia/chemically induced; Febrile Neutropenia/epidemiology; Febrile Neutropenia/prevention & control; Granulocyte Colony-Stimulating Factor/therapeutic use; Humans; Incidence; Retrospective Studies

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Breast Neoplasms / Febrile Neutropenia Type of study: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: Ja Year: 2020 Type: Article

Search on Google

XML

PubMed Links